Broadfin Capital as of Sept. 30, 2018
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 47 positions in its portfolio as reported in the September 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
iShares Russell 2000 Index (IWM) | 9.9 | $67M | 400k | 168.55 | |
Iovance Biotherapeutics (IOVA) | 8.1 | $55M | 4.9M | 11.25 | |
La Jolla Pharmaceuticl Com Par | 6.4 | $43M | 2.2M | 20.13 | |
Zogenix | 4.8 | $33M | 658k | 49.60 | |
Adma Biologics (ADMA) | 4.1 | $28M | 4.5M | 6.21 | |
Retrophin | 4.0 | $27M | 938k | 28.73 | |
Adamas Pharmaceuticals | 3.9 | $27M | 1.3M | 20.02 | |
Tandem Diabetes Care (TNDM) | 3.6 | $25M | 573k | 42.84 | |
Aratana Therapeutics | 3.5 | $24M | 4.1M | 5.84 | |
Amarin Corporation (AMRN) | 3.5 | $24M | 1.5M | 16.27 | |
Corium Intl | 3.3 | $23M | 2.4M | 9.51 | |
Catalyst Pharmaceutical Partners (CPRX) | 2.9 | $19M | 5.1M | 3.78 | |
Mirati Therapeutics | 2.5 | $17M | 358k | 47.10 | |
Antares Pharma | 2.3 | $16M | 4.6M | 3.36 | |
SPDR S&P Biotech (XBI) | 2.3 | $15M | 160k | 95.87 | |
Nanostring Technologies (NSTGQ) | 2.2 | $15M | 850k | 17.83 | |
Recro Pharma | 2.1 | $15M | 2.0M | 7.11 | |
Pacific Biosciences of California (PACB) | 2.0 | $14M | 2.5M | 5.41 | |
Integra LifeSciences Holdings (IART) | 1.9 | $13M | 197k | 65.87 | |
Strongbridge Bioph shs usd | 1.8 | $12M | 2.6M | 4.85 | |
Heron Therapeutics (HRTX) | 1.8 | $12M | 391k | 31.65 | |
BioDelivery Sciences International | 1.8 | $12M | 4.4M | 2.80 | |
Flamel Technologies Sa | 1.8 | $12M | 2.8M | 4.39 | |
Teligent | 1.8 | $12M | 3.1M | 3.95 | |
Xenon Pharmaceuticals (XENE) | 1.7 | $12M | 896k | 13.20 | |
Tesaro | 1.3 | $9.0M | 230k | 39.01 | |
Horizon Pharma | 1.2 | $8.0M | 411k | 19.58 | |
Strata Skin Sciences | 1.1 | $7.7M | 2.2M | 3.54 | |
Sierra Oncology | 1.0 | $7.0M | 4.1M | 1.70 | |
Intersect Ent | 1.0 | $6.7M | 234k | 28.75 | |
Sol Gel Technologies (SLGL) | 0.9 | $6.4M | 848k | 7.50 | |
Livanova Plc Ord (LIVN) | 0.9 | $6.3M | 51k | 123.96 | |
AngioDynamics (ANGO) | 0.9 | $6.3M | 289k | 21.74 | |
Quotient | 0.9 | $6.1M | 805k | 7.55 | |
Noveliontherapeuti.. | 0.8 | $5.8M | 1.9M | 2.96 | |
Global Blood Therapeutics In | 0.8 | $5.7M | 150k | 38.00 | |
Idera Pharmaceuticals | 0.8 | $5.6M | 629k | 8.91 | |
Alnylam Pharmaceuticals (ALNY) | 0.8 | $5.4M | 62k | 87.52 | |
Dex (DXCM) | 0.5 | $3.5M | 24k | 143.06 | |
Kala Pharmaceuticals | 0.5 | $3.4M | 346k | 9.87 | |
Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.5 | $3.3M | 15M | 0.22 | |
Kalvista Pharmaceuticals (KALV) | 0.5 | $3.3M | 150k | 22.11 | |
Viewray (VRAYQ) | 0.3 | $2.3M | 250k | 9.36 | |
Scynexis | 0.3 | $2.3M | 1.9M | 1.20 | |
Alphatec Holdings (ATEC) | 0.3 | $2.3M | 670k | 3.37 | |
Vericel (VCEL) | 0.3 | $1.9M | 133k | 14.15 | |
Oncomed Pharmaceuticals | 0.1 | $424k | 200k | 2.12 |